The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are ...

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human ...

An announcement from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On June 2, 2025, Telomir Pharmaceuticals announced its ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

Under the agreement, Intragrand has granted Transpire Bio an exclusive license to develop, manufacture, and commercialize ITG ...

In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its ...

The need for drying technologies to stabilize drug products containing biologics Drug products containing active biological ...